Genetec Technology Berhad Temettü
Temettü kriter kontrolleri 2/6
Genetec Technology Berhad is a dividend paying company with a current yield of 2.92% that is well covered by earnings.
Anahtar bilgiler
2.9%
Temettü verimi
-0.4%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | 2.5% |
| Gelecekteki Temettü Verimi | 2.9% |
| Temettü Büyümesi | 3.9% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | RM 0.020 |
| Ödeme oranı | 18% |
Son temettü güncellemeleri
Recent updates
Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 23
Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Sep 22Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be
Aug 27Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%
Aug 19Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?
Aug 06Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable
Feb 26Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement
Jan 15Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders
Sep 22Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?
Feb 08Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency
Dec 28Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?
Nov 17Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital
Aug 16Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet
Jul 21Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 30Genetec Technology Berhad's (KLSE:GENETEC) Intrinsic Value Is Potentially 93% Above Its Share Price
Apr 28Why We Like The Returns At Genetec Technology Berhad (KLSE:GENETEC)
Mar 23Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Feb 24Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Nov 04The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon
Sep 08Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders
Aug 05Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Jul 30Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?
Jun 11How Well Is Genetec Technology Berhad (KLSE:GENETEC) Allocating Its Capital?
Feb 10Why Genetec Technology Berhad's (KLSE:GENETEC) CEO Pay Matters
Jan 14Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly
Dec 24
Genetec Technology Berhad's (KLSE:GENETEC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Dec 03Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: GENETEC has been paying a dividend for less than 10 years and during this time payments have been volatile.
Büyüyen Temettü: GENETEC's dividend payments have increased, but the company has only paid a dividend for 6 years.
Piyasaya Karşı Temettü Getirisi
| Genetec Technology Berhad Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (GENETEC) | 2.9% |
| Pazarın Alt %25'i (MY) | 2.0% |
| Pazarın En İyi %25'i (MY) | 4.8% |
| Sektör Ortalaması (Semiconductor) | 1.8% |
| Analist tahmini (GENETEC) (3 yıla kadar) | 2.9% |
Önemli Temettü: GENETEC's dividend (2.92%) is higher than the bottom 25% of dividend payers in the MY market (1.96%).
Yüksek Temettü: GENETEC's dividend (2.92%) is low compared to the top 25% of dividend payers in the MY market (4.82%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its low payout ratio (17.8%), GENETEC's dividend payments are well covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: With its high cash payout ratio (98.8%), GENETEC's dividend payments are not well covered by cash flows.